Cardiolynx ^Company

Cardiolynx is a company that focuses on developing new treatments for cardio-metabolic diseases, which are conditions related to the heart and metabolism. These diseases are becoming more prevalent due to longer life expectancies. Cardiolynx aims to optimize and combine established therapies with the multi-functional messenger nitric oxide to create more effective treatments. The company intends to develop a broad portfolio of therapies to improve patient care and quality of life.